Related references
Note: Only part of the references are listed.Regulatory T cells in cancer immunotherapy
Atsushi Tanaka et al.
CELL RESEARCH (2017)
Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
Heather Torrey et al.
SCIENCE SIGNALING (2017)
Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer
Xin Chen et al.
SCIENCE SIGNALING (2017)
Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
Heather Torrey et al.
SCIENCE SIGNALING (2017)
Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer
Xin Chen et al.
SCIENCE SIGNALING (2017)
Low intratumoral regulatory T cells and high peritumoral CD8+ T cells relate to long-term survival in patients with pancreatic ductal adenocarcinoma after pancreatectomy
Li Liu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy
J. M. Pitt et al.
ANNALS OF ONCOLOGY (2016)
TNF-α priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatment
Antonio Pierini et al.
BLOOD (2016)
Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells
Mathieu Leclerc et al.
BLOOD (2016)
Worse outcome in breast cancer with higher tumor-infiltrating FOXP3+Tregs : a systematic review and meta-analysis
Jiafeng Shou et al.
BMC CANCER (2016)
Targeting regulatory T cells in tumors
Chang Liu et al.
FEBS JOURNAL (2016)
Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion
Martin Chopra et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Suppressive activity of human regulatory T cells is maintained in the presence of TNF
Bruno Zaragoza et al.
NATURE MEDICINE (2016)
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Itay Tirosh et al.
SCIENCE (2016)
Expression of TNFR2 by regulatory T cells in peripheral blood is correlated with clinical pathology of lung cancer patients
Fan Yan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
PD-L1 Blockade Differentially Impacts Regulatory T Cells from HIV-Infected Individuals Depending on Plasma Viremia
Cristina Peligero et al.
PLOS PATHOGENS (2015)
The role of regulatory T cells in cancer immunology
Theresa L. Whiteside
IMMUNOTARGETS AND THERAPY (2015)
Lenalidomide-based maintenance therapy reduces TNF Receptor 2 on CD4 T cells and enhances immune effector function in acute myeloid leukemia patients
Chindu Govindaraj et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Expression of tumour necrosis factor-α and its receptors in Hodgkin lymphoma
Shoko Nakayama et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Ag-Presenting CpG-Activated pDCs Prime Th17 Cells That Induce Tumor Regression
Leslie Guery et al.
CANCER RESEARCH (2014)
Reducing TNF Receptor 2+ Regulatory T Cells via the Combined Action of Azacitidine and the HDAC Inhibitor, Panobinostat for Clinical Benefit in Acute Myeloid Leukemia Patients
Chindu Govindaraj et al.
CLINICAL CANCER RESEARCH (2014)
Regulatory T cells in cancer immunotherapy
Hiroyoshi Nishikawa et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients
Geok Choo Sim et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Transmembrane TNF-α Promotes Suppressive Activities of Myeloid-Derived Suppressor Cells via TNFR2
Xin Hu et al.
JOURNAL OF IMMUNOLOGY (2014)
Enhancement of Tumor-Specific T Cell-Mediated Immunity in Dendritic Cell-Based Vaccines by Mycobacterium tuberculosis Heat Shock Protein X
In Duk Jung et al.
JOURNAL OF IMMUNOLOGY (2014)
Effective Chemoimmunotherapy with Anti-TGFβ Antibody and Cyclophosphamide in a Mouse Model of Breast Cancer
Xin Chen et al.
PLOS ONE (2014)
Streptavidin: A Novel Immunostimulant for the Selection and Delivery of Autologous and Syngeneic Tumor Vaccines
Chris Weir et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+Tregs within the tumor microenvironment
Chindu Govindaraj et al.
CLINICAL IMMUNOLOGY (2013)
Deciphering and Reversing Tumor Immune Suppression
Greg T. Motz et al.
IMMUNITY (2013)
Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer
Yung-Chang Lin et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
TNFR2 Is Critical for the Stabilization of the CD4+Foxp3+ Regulatory T Cell Phenotype in the Inflammatory Environment
Xin Chen et al.
JOURNAL OF IMMUNOLOGY (2013)
Tumor Necrosis Factor Receptor 2: Its Contribution to Acute Cellular Rejection and Clear Cell Renal Carcinoma
Jun Wang et al.
BIOMED RESEARCH INTERNATIONAL (2013)
TNF signaling drives myeloid-derived suppressor cell accumulation
Xueqiang Zhao et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Intratumoral Injection of CpG Oligonucleotides Induces the Differentiation and Reduces the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells
Yuko Shirota et al.
JOURNAL OF IMMUNOLOGY (2012)
Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells
Hiroyuki Tao et al.
LUNG CANCER (2012)
CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with Immunotherapy in Cancer Patients
Andrew J. Rech et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer
Helene Pere et al.
ONCOIMMUNOLOGY (2012)
Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity
Paul J. Tacken et al.
BLOOD (2011)
CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Christine Zoglmeier et al.
CLINICAL CANCER RESEARCH (2011)
TNF optimally activatives regulatory T cells by inducing TNF receptor superfamily members TNFR2, 4-1BB and OX40
Ryoko Hamano et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Cytokine Induction of Tumor Necrosis Factor Receptor 2 Is Mediated by STAT3 in Colon Cancer Cells
Kathryn E. Hamilton et al.
MOLECULAR CANCER RESEARCH (2011)
TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanisms
H. Rauert et al.
CELL DEATH & DISEASE (2011)
Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood
Xin Chen et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
In vivo depletion of CD4+FOXP3+ Treg cells by the PC61 anti-CD25 monoclonal antibody is mediated by FcγRIII+ phagocytes
Yulius Y. Setiady et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs
Yenkel Grinberg-Bleyer et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Expression of Costimulatory TNFR2 Induces Resistance of CD4+FoxP3- Conventional T Cells to Suppression by CD4+ FoxP3+ Regulatory T Cells
Xin Chen et al.
JOURNAL OF IMMUNOLOGY (2010)
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
Joerg Vollmer et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Massive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancer
Francois M. Lemoine et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
Engagement of TLR2 Does not Reverse the Suppressor Function of Mouse Regulatory T Cells, but Promotes Their Survival
Qian Chen et al.
JOURNAL OF IMMUNOLOGY (2009)
IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T Cells
Babak Baban et al.
JOURNAL OF IMMUNOLOGY (2009)
In vivo colocalization of antigen and cytidyl guanosyl within dendritic cells is associated with the efficacy of cancer immunotherapy
Stefan Nierkens et al.
CANCER RESEARCH (2008)
Expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells:: Applicability to tumor-infiltrating T regulatory cells
Xin Chen et al.
JOURNAL OF IMMUNOLOGY (2008)
Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells
Xin Chen et al.
JOURNAL OF IMMUNOLOGY (2007)
Cytokine responses to CpG DNA in human leukocytes
J. gren et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2006)
Immunotherapeutic uses of CpG oligodeoxynucleotides
DM Klinman
NATURE REVIEWS IMMUNOLOGY (2004)
Induction of potent antitumor immunity by in situ targeting of intraturnoral DCs
K Furumoto et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells
EA Moseman et al.
JOURNAL OF IMMUNOLOGY (2004)
Share Paper
